TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 62nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 67nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 83nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 85nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 290nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:In vitro inhibition of phosphodiesterase (PDE V).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 360nMAssay Description:Inhibition of cAMP Phosphodiesterase 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 430nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 450nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 550nMAssay Description:Inhibition of cAMP PDE 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 570nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of cAMP Phosphodiesterase 3More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 770nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 840nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 910nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 940nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 960nMAssay Description:Inhibition of cAMP Phosphodiesterase 3More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 1.02E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 1.15E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 1.22E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 1.42E+3nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE V).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 1.82E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 2.10E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 2.10E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 2.20E+3nMAssay Description:In vitro inhibitory activity against cAMP PDE III.More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 2.30E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A/1B/1C(Homo sapiens (Human))
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE I).More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:In vitro inhibition of phosphodiesterase (PDE III).More data for this Ligand-Target Pair